ID   RMG-II
AC   CVCL_2803
SY   RMG2; RMG-2
DR   BTO; BTO_0004929
DR   BioSample; SAMN03470819
DR   cancercelllines; CVCL_2803
DR   CGH-DB; 335-2
DR   CGH-DB; 9363-4
DR   Cosmic; 1152557
DR   Cosmic; 2582801
DR   GEO; GSM1176284
DR   JCRB; FDSC0028
DR   JCRB; IFO50316
DR   JCRB; JCRB0172.1
DR   Progenetix; CVCL_2803
DR   Wikidata; Q54950667
RX   PubMed=1715339;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
RX   PubMed=24023729;
RX   PubMed=25846456;
RX   PubMed=25960936;
CC   Population: Japanese.
CC   Doubling time: ~58 hours (PubMed=1715339); 84 hours (Note=Lot 07132004), ~51 hours (Note=Lot 02032016) (JCRB=JCRB0172.1).
CC   HLA typing: A*02:07,02:07; B*35:01,35:01; C*03:03,03:03; DQB1*02:02,02:02 (PubMed=25960936).
CC   Discontinued: JCRB; IFO50316; true.
CC   Discontinued: JCRB; FDSC0028; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB0172.1
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
RX   PubMed=17671176; DOI=10.1158/0008-5472.CAN-06-4567;
RA   Kikuchi, Ryoko
RA   Tsuda, Hitoshi
RA   Kanai, Yae
RA   Kasamatsu, Takahiro
RA   Sengoku, Kazuo
RA   Hirohashi, Setsuo
RA   Inazawa, Johji
RA   Imoto, Issei
RT   "Promoter hypermethylation contributes to frequent inactivation of a
RT   putative conditional tumor suppressor gene connective tissue growth
RT   factor in ovarian cancer.";
RL   Cancer Res. 67:7095-7105(2007).
//
RX   PubMed=11330945; DOI=10.1006/gyno.2001.6132;
RA   Watanabe, Takafumi
RA   Imoto, Issei
RA   Kosugi, Yoshinori
RA   Ishiwata, Isamu
RA   Inoue, Satoshi
RA   Takayama, Masaomi
RA   Sato, Akira
RA   Inazawa, Johji
RT   "A novel amplification at 17q21-23 in ovarian cancer cell lines
RT   detected by comparative genomic hybridization.";
RL   Gynecol. Oncol. 81:172-177(2001).
//
RX   PubMed=25846456; DOI=10.3892/ijo.2015.2951;
RA   Takenaka, Masataka
RA   Saito, Motonobu
RA   Iwakawa, Reika
RA   Yanaihara, Nozomu
RA   Saito, Misato
RA   Kato, Mamoru
RA   Ichikawa, Hitoshi
RA   Shibata, Tatsuhiro
RA   Yokota, Jun
RA   Okamoto, Aikou
RA   Kohno, Takashi
RT   "Profiling of actionable gene alterations in ovarian cancer by
RT   targeted deep sequencing.";
RL   Int. J. Oncol. 46:2389-2398(2015).
//
RX   PubMed=12417041; DOI=10.1111/j.1349-7006.2002.tb01213.x; PMCID=PMC5926887;
RA   Watanabe, Takafumi
RA   Imoto, Issei
RA   Katahira, Tomoyuki
RA   Hirasawa, Akira
RA   Ishiwata, Isamu
RA   Emi, Mitsuru
RA   Takayama, Masaomi
RA   Sato, Akira
RA   Inazawa, Johji
RT   "Differentially regulated genes as putative targets of amplifications
RT   at 20q in ovarian cancers.";
RL   Jpn. J. Cancer Res. 93:1114-1122(2002).
//
RX   PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981;
RA   Boegel, Sebastian
RA   Lower, Martin
RA   Bukur, Thomas
RA   Sahin, Ugur
RA   Castle, John C.
RT   "A catalog of HLA type, HLA expression, and neo-epitope candidates in
RT   human cancer cell lines.";
RL   OncoImmunology 3:e954893.1-e954893.12(2014).
//
RX   PubMed=24023729; DOI=10.1371/journal.pone.0072162; PMCID=PMC3762837;
RA   Anglesio, Michael S.
RA   Wiegand, Kimberly C.
RA   Melnyk, Nataliya
RA   Chow, Christine
RA   Salamanca, Clara M.
RA   Prentice, Leah M.
RA   Senz, Janine
RA   Yang, Winnie
RA   Spillman, Monique Ann
RA   Cochrane, Dawn R.
RA   Shumansky, Karey
RA   Shah, Sohrab P.
RA   Kalloger, Steve E.
RA   Huntsman, David G.
RT   "Type-specific cell line models for type-specific ovarian cancer
RT   research.";
RL   PLoS ONE 8:e72162.1-e72162.13(2013).
//
RX   PubMed=1715339; DOI=10.1111/j.1349-7006.1991.tb02713.x; PMCID=PMC5918546;
RA   Nozawa, Shiro
RA   Yajima, Masazumi
RA   Sasaki, Hirosuke
RA   Tsukazaki, Katsumi
RA   Aoki, Daisuke
RA   Sakayori, Motoko
RA   Udagawa, Yasuhiro
RA   Kobayashi, Toshifumi
RA   Sato, Ichiro
RA   Furusako, Shoji
RA   Mochizuki, Hiroshi
RT   "A new CA125-like antigen (CA602) recognized by two monoclonal
RT   antibodies against a newly established ovarian clear cell carcinoma
RT   cell line (RMG-II).";
RL   Jpn. J. Cancer Res. 82:854-861(1991).
//